The Brussels CST2013 – Clinical Trial Supply 2013 symposium is a premier discussion designed with direct contribution and aid of practitioners. Colleagues and experts engaged in both strategic and daily activities concerning bottle necks within the clinical trial supply management. CTS 2013 is intended for professionals from the field concerned with expanding their knowledge base, learning and bench marking from practical and new clinical trial supply cases.
The programme draws strength from addressing fundamental difficulties and critical points within the CTS Chain such as Technology (IVRS) and Data integration, Labelling (booklets) and packaging,Qualified Person (role) to Material Forecasting among others. Other issues such as the corrective interpretation of regulatory, standardisation of processes and international requirements are also assessed. These may include Good Clinical Practice (GCP), EU Clinical Trials Directive 2001/20/EC – Good Manufacturing Practice (GMP): Article 9 or Article 13. And GMP: EudralexVol 4 - EU GMP Guide; Orange Guide, part one as well as annex 13 dedicated Investigational Medicinal Products (IMPs).
The symposium covers key drivers and inhibitors in relation to where the main focus will be within the next 12 to 18 months. A homogenous set of challenges have been identified subject to the nature of clinical supplies/studies. We suggest the requirements to deal and manage them effectively be they multi-country CTS chains or inventory limitations are similar in nature. Accordingly if you are dealing or responsible for CTS chain/s you will find the conference to be an unmatched learning experience.